Single Cell Genomics And Proteomics Market
By Process Step;
Cell Isolation, Sample Preparation and Genomics AnalysisBy Technology;
Tubing PCR, qPCR, Microarray, Next-Generation Sequencing and OthersBy Components;
Instruments, Reagents and ServicesBy Reagents;
Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents and Protein Fractionation ReagentsBy Proteomics Services &
Software; Core Proteomics Services and Bioinformatics Software & ServicesBy Single Cell Genomics Applications;
Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells, Cell Differentiation & Reprograming Method and OthersBy Application;
Drug Discovery, Disease Diagnosis and OthersBy End-Users;
Academic Institutes, Biopharmaceutical Companies and Clinical Research InstitutesBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Single Cell Genomics And Proteomics Market Overview
Single Cell Genomics and Proteomics Market (USD Million)
Single Cell Genomics and Proteomics Market was valued at USD 4,066.40 million in the year 2024. The size of this market is expected to increase to USD 13,030.44 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 18.1%.
Single Cell Genomics And Proteomics Market
*Market size in USD million
CAGR 18.1 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 18.1 % |
| Market Size (2024) | USD 4,066.40 Million |
| Market Size (2031) | USD 13,030.44 Million |
| Market Concentration | Low |
| Report Pages | 365 |
Major Players
- Illumina, Inc.
- Fluidigm Corporation
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Agilent Technologies
- Merck KGaA (EMD Millipore)
- Qiagen N.V.
- Becton, Dickinson and Company (BD)
- NanoString Technologies
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Single Cell Genomics And Proteomics Market
Fragmented - Highly competitive market without dominant players
The Single Cell Genomics And Proteomics Market is growing rapidly due to increasing demand for high-resolution cellular profiling and personalized medicine. Over 65% of researchers are adopting single-cell sequencing to analyze cellular heterogeneity and discover novel biomarkers. Advanced omics technologies are enhancing capabilities for understanding disease mechanisms and developing targeted therapies.
Rising Adoption in Drug Discovery and Development
The integration of single-cell analysis into drug discovery pipelines has accelerated significantly, with around 58% of pharmaceutical companies utilizing genomic and proteomic profiling to identify therapeutic targets. The ability to evaluate drug responses at the single-cell level supports the development of more effective and safer treatment strategies, driving innovation across precision medicine.
Growing Application in Personalized Healthcare
The shift toward personalized treatment strategies has significantly increased the adoption of single-cell genomics and proteomics. Over 55% of healthcare providers leverage these techniques to customize therapeutic approaches based on individual cellular profiles. The technology’s ability to decode cell-to-cell variations offers transformative potential in oncology, immunology, and rare disease research.
Increasing Investments and Collaborative Research
Expanding public-private partnerships and increased funding have fueled innovation within the market. Nearly 60% of academic and commercial research institutes are collaborating to advance multi-omics integration and develop next-generation diagnostic solutions. This growing ecosystem of research-driven alliances is accelerating technological adoption and expanding opportunities for translational medicine.
Single Cell Genomics And Proteomics Market Recent Developments
-
In April 2024, 10x Genomics, Inc. launched an innovative single-cell multiomics platform that allows integrated genomic and proteomic analysis for precise cellular characterization and discovery.
-
In September 2024, Thermo Fisher Scientific Inc. entered a strategic partnership with a top research institute to develop AI-powered single-cell proteomics systems designed for faster data processing and deeper biological insights.
Single Cell Genomics And Proteomics Market Segment Analysis
In this report, the Single Cell Genomics And Proteomics Market has been segmented by Process Step, Technology, Components, Reagents, Proteomics Services & Software, Single Cell Genomics Applications, Application, End-Users, and Geography.
Single Cell Genomics And Proteomics Market, Segmentation by Process Step
The Process Step segmentation represents the stages of analyzing genomic and proteomic data at the single-cell level. The process requires high precision in cell isolation and sample preparation to ensure data accuracy and reproducibility in downstream analysis.
Cell Isolation
Cell isolation is a critical step involving techniques such as flow cytometry, microfluidics, and magnetic separation. Innovations in automated single-cell sorting systems are enabling higher throughput and purity, essential for accurate genomic and proteomic profiling.
Sample Preparation
Sample preparation involves lysis, amplification, and enrichment protocols that maintain cellular integrity. Advanced nanotechnology-enabled workflows and microdroplet systems are improving efficiency and minimizing sample loss, facilitating precise molecular characterization.
Genomics Analysis
Genomics analysis utilizes sequencing, amplification, and computational tools to explore genetic heterogeneity at a single-cell resolution. The integration of multi-omics data is revolutionizing disease pathway mapping and biomarker discovery in complex biological systems.
Single Cell Genomics And Proteomics Market, Segmentation by Technology
The Technology segmentation identifies the tools and platforms used for sequencing and protein profiling at the cellular level. Continuous technological evolution is enhancing data accuracy, throughput, and integration capabilities for large-scale studies.
Tubing PCR
Tubing PCR is an advanced version of polymerase chain reaction that enables precise amplification of single-cell DNA. Its role in rare variant detection and low-copy genomic analysis makes it vital for applications in oncology and immunology research.
qPCR
Quantitative PCR (qPCR) remains a cornerstone for gene expression analysis due to its sensitivity and quantitative precision. It provides real-time insights into molecular pathways and serves as a validation tool for next-generation sequencing outputs.
Microarray
Microarray technologies enable parallel analysis of thousands of genes or proteins, facilitating large-scale expression profiling and genetic variation studies. Advancements in chip-based microfluidics have increased throughput and minimized reagent use.
Next-Generation Sequencing
Next-generation sequencing (NGS) dominates the market owing to its ability to deliver high-depth genomic data and variant detection across thousands of single cells. It supports cancer genomics, stem cell biology, and metagenomic profiling with unmatched accuracy and scalability.
Others
The Others segment includes emerging tools such as single-molecule sequencing and digital PCR, which provide enhanced resolution and lower error rates. These innovations are supporting the shift toward real-time, single-cell diagnostics.
Single Cell Genomics And Proteomics Market, Segmentation by Components
The Components segmentation encompasses the core building blocks that enable single-cell data generation and interpretation. Growth in this category is driven by increasing instrument automation and demand for customized reagent kits.
Instruments
Instruments include sequencing platforms, mass spectrometers, and cell sorters that enable high-throughput single-cell analysis. Automation, miniaturization, and AI-based controls are transforming laboratory workflows and reducing analysis time.
Reagents
Reagents form a critical component in sample preparation and biochemical assays. The introduction of high-sensitivity reagents compatible with low-volume samples is enhancing reproducibility and detection accuracy in single-cell studies.
Services
Services include analytical, consulting, and bioinformatics support that aid in data management and interpretation. Contract research organizations (CROs) are offering outsourced single-cell proteomics services to accelerate discovery and clinical validation processes.
Single Cell Genomics And Proteomics Market, Segmentation by Reagents
The Reagents segmentation details the specific reagents used in proteomic assays and analytical methods. Technological innovation is leading to the creation of high-purity reagents and multiplex-compatible kits designed for precision research.
Immunoassay Reagents
Immunoassay reagents are used for protein quantification and detection through antibody-antigen interactions. They enable targeted protein analysis in disease diagnosis and biomarker validation.
Spectroscopy Reagents
Spectroscopy reagents are essential for molecular identification using optical methods such as Raman and mass spectroscopy. Their high sensitivity aids in the detection of trace-level biomolecules in single-cell samples.
Chromatography Reagents
Chromatography reagents facilitate protein separation and purification in proteomic workflows. The development of nano-scale chromatography systems is improving throughput and reducing sample contamination risks.
Protein Microarray Reagents
Protein microarray reagents enable high-density screening of protein interactions, supporting drug target discovery and functional proteomics. Enhanced surface chemistries are improving binding efficiency and detection limits.
X-Ray Crystallography Reagents
X-ray crystallography reagents are used for detailed protein structure determination. The miniaturization of crystallization platforms has expanded their use in single-protein structural analysis.
Electrophoresis Reagents
Electrophoresis reagents remain fundamental for protein and nucleic acid separation. Advances in microfluidic gel systems are enhancing resolution and enabling single-cell electrophoretic profiling.
Protein Fractionation Reagents
Protein fractionation reagents support the isolation and quantification of cellular proteins from complex matrices. Their compatibility with mass spectrometry and liquid chromatography techniques ensures improved analytical sensitivity.
Single Cell Genomics And Proteomics Market, Segmentation by Proteomics Services & Software
The Proteomics Services & Software segmentation covers analytical solutions that process and interpret single-cell protein data. The integration of cloud-based bioinformatics tools is accelerating data-driven discoveries.
Core Proteomics Services
Core proteomics services include mass spectrometry-based analysis, peptide mapping, and protein quantification. Service providers are offering customized proteome profiling to support pharmaceutical and academic research initiatives.
Bioinformatics Software & Services
Bioinformatics software & services facilitate data visualization, pathway analysis, and AI-driven interpretation. Cloud integration and machine learning algorithms are enabling predictive modeling and comprehensive single-cell datasets integration.
Single Cell Genomics And Proteomics Market, Segmentation by Single Cell Genomics Applications
The Single Cell Genomics Applications segmentation explores the use cases of single-cell technology in understanding genetic diversity and disease mechanisms. The rise of precision medicine has increased adoption across multiple research domains.
Genomic Variation
Genomic variation studies help identify mutations and polymorphisms within individual cells. These insights are pivotal for cancer genomics, rare disease studies, and evolutionary biology research.
Subpopulation Characterization
Subpopulation characterization enables the identification of cellular heterogeneity within tissues. This analysis supports breakthroughs in immunology and neuroscience by mapping functional differences among similar cell types.
Circulating Tumor Cells
Circulating tumor cell (CTC) analysis is crucial for understanding metastasis and monitoring cancer progression. Advanced sequencing and proteomic profiling of CTCs are improving early detection and personalized oncology strategies.
Cell Differentiation & Reprograming Method
Cell differentiation and reprograming studies leverage single-cell data to map cellular lineage and functional transformation. These insights are key to developing regenerative medicine therapies and stem cell research.
Others
The Others category includes applications in microbial genomics and developmental biology, where single-cell technologies uncover molecular mechanisms governing cell function and growth dynamics.
Single Cell Genomics And Proteomics Market, Segmentation by Application
The Application segmentation demonstrates the growing integration of single-cell studies across biomedical research and clinical development. These applications contribute to improved disease modeling and therapeutic design.
Drug Discovery
Drug discovery applications dominate the market, as single-cell analysis allows for target identification, compound screening, and mechanism-of-action studies. Integration with AI platforms is enhancing precision in candidate selection and toxicity prediction.
Disease Diagnosis
Disease diagnosis leverages single-cell sequencing and proteomics for early detection and biomarker discovery. These techniques are increasingly used in oncology, neurology, and infectious disease diagnostics to capture molecular variations undetectable by bulk methods.
Others
The Others segment encompasses applications in environmental genomics and microbial ecology, expanding the role of single-cell technology beyond biomedical domains.
Single Cell Genomics And Proteomics Market, Segmentation by End-Users
The End-Users segmentation outlines the key stakeholders driving adoption. Increased collaboration between academic institutions and biopharmaceutical companies is accelerating research translation and commercialization.
Academic Institutes
Academic institutes are major contributors, focusing on fundamental research and technology validation. Funding support for single-cell laboratories and multi-omics integration is expanding their global research footprint.
Biopharmaceutical Companies
Biopharmaceutical companies are utilizing single-cell analysis for drug target discovery and clinical pipeline optimization. The adoption of high-throughput technologies and bioinformatics automation is enhancing efficiency in preclinical studies.
Clinical Research Institutes
Clinical research institutes use these technologies for personalized therapy development and diagnostic biomarker validation. Collaborations with hospitals and biotech startups are fostering translational research applications in oncology and rare diseases.
Single Cell Genomics And Proteomics Market, Segmentation by Geography
In this report, the Single Cell Genomics And Proteomics Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America leads the market owing to extensive genomics research funding, strong presence of biotech companies, and rapid adoption of NGS and mass spectrometry platforms. The U.S. remains the hub for multi-omics research and data analytics innovation.
Europe
Europe maintains a robust position with government initiatives supporting precision medicine and genomic data infrastructure. Nations such as Germany, U.K., and France are key contributors to proteogenomic research collaborations.
Asia Pacific
Asia Pacific exhibits strong growth fueled by biotechnology expansion in China, Japan, and India. Rising investments in genomic sequencing centers and bioinformatics infrastructure are enhancing regional capabilities.
Middle East & Africa
Middle East & Africa are emerging regions with increasing emphasis on healthcare genomics and academic research partnerships. Growing focus on rare disease studies and government-led funding programs are gradually expanding market adoption.
Latin America
Latin America shows steady growth as clinical and academic institutes invest in genomic medicine and cancer research. Regional collaboration with global research networks is accelerating technology adoption in countries such as Brazil and Mexico.
Single Cell Genomics And Proteomics Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Single Cell Genomics and Proteomics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological advancements in single cell analysis techniques
-
Increasing investments in genomics and proteomics research - single cell genomics and proteomics market is experiencing robust growth, driven primarily by increasing investments in genomic and proteomic research. These fields have witnessed significant advancements due to technological innovations enabling the analysis of individual cells at unprecedented resolution. Single cell genomics allows researchers to explore the genetic makeup of individual cells within complex tissues or heterogeneous populations, providing insights into cellular heterogeneity and function that were previously inaccessible. Similarly, single cell proteomics enables the precise measurement of protein expression at the single-cell level, offering complementary information to genomics data.
Investments in genomics and proteomics research have been fueled by growing recognition of their potential applications in understanding disease mechanisms, discovering biomarkers, and developing personalized therapies. Pharmaceutical and biotechnology companies are increasingly leveraging single cell technologies to accelerate drug discovery and development processes, aiming to create more targeted and effective treatments. Moreover, government initiatives and funding support across various countries further propel market growth, fostering collaborations between academia, industry, and research institutions.
Technological advancements such as high-throughput sequencing, microfluidics, and mass spectrometry have expanded the capabilities of single cell genomics and proteomics, driving down costs and improving efficiency. These innovations are crucial in addressing challenges related to sample heterogeneity and rare cell populations, thereby broadening the scope of applications in both basic research and clinical settings. As the field continues to evolve, the global market for single cell genomics and proteomics is poised for sustained growth, with ongoing investments expected to further drive innovation and propel the development of new therapeutic interventions and diagnostic tools.
Restraints
- High cost associated with single cell genomics and proteomics technologies
-
Complexity in data analysis and interpretation - single cell genomics and proteomics market has seen remarkable growth driven by advancements in technology that enable the study of individual cells at unprecedented resolution. This burgeoning field offers profound insights into cellular heterogeneity and function, revolutionizing our understanding of biology and disease. However, this progress has also introduced significant challenges, particularly in data analysis and interpretation, due to the sheer complexity and volume of data generated from single cell studies.
Data analysis in single cell genomics and proteomics involves processing vast amounts of data from individual cells, often requiring sophisticated computational tools and algorithms. Each cell's molecular profile generates a complex dataset, including genomic sequences, transcriptomic profiles, and proteomic data, which must be integrated and analyzed comprehensively. The variability inherent in single cell data adds another layer of complexity, necessitating robust statistical methods to distinguish true biological signals from noise.
Interpreting single cell data poses additional challenges as researchers strive to derive meaningful insights from intricate datasets. Understanding cellular heterogeneity and identifying rare cell populations or subtle molecular changes requires advanced bioinformatics approaches and computational modeling. Moreover, integrating multi-omics data from the same single cells presents technical hurdles, demanding innovative strategies to correlate genomic, transcriptomic, and proteomic information accurately.
Opportunities
- Growing applications in personalized medicine
-
Rising demand for biomarker discovery - single-cell genomics and proteomics market is experiencing a significant surge in demand driven by the growing need for biomarker discovery across various fields including oncology, immunology, neuroscience, and infectious diseases. Single-cell analysis enables researchers to delve deeper into the heterogeneity of cell populations, providing insights that traditional bulk analysis methods cannot achieve. This technology allows for the identification and characterization of rare cell types, detection of subtle molecular variations between individual cells, and exploration of complex biological mechanisms at a single-cell resolution.
One of the key factors fueling the market growth is the increasing application of single-cell genomics and proteomics in personalized medicine. By analyzing individual cells, researchers can identify unique biomarkers associated with disease progression, treatment response, and patient outcomes. This personalized approach holds promise for developing targeted therapies and improving clinical decision-making. Moreover, advancements in technology, such as high-throughput sequencing and mass spectrometry, have enhanced the efficiency and scalability of single-cell analysis, further driving its adoption in both academic research and clinical settings.
The pharmaceutical and biotechnology industries are also significant contributors to the rising demand for single-cell genomics and proteomics. These sectors utilize single-cell technologies to accelerate drug discovery and development processes, validate therapeutic targets, and assess drug efficacy and safety profiles at a cellular level. As the understanding of cellular heterogeneity deepens and analytical techniques continue to evolve, the market for single-cell genomics and proteomics is poised for continued expansion, offering unprecedented opportunities for biomarker discovery and therapeutic innovation in healthcare.
Single Cell Genomics And Proteomics Market Competitive Landscape Analysis
Single Cell Genomics And Proteomics Market is witnessing intense competition with companies adopting innovative strategies, forging partnerships, and exploring new technological advancements to enhance their product portfolios. Growing demand for high-resolution molecular profiling is driving market expansion as mergers and collaboration initiatives accelerate sector-wide integration.
Market Structure and ConcentrationThe market reflects moderate concentration with key players commanding significant percentages of share, while emerging innovators continue to disrupt traditional models. Increased emphasis on merger activities and research alliances is reshaping competitive positioning, creating diversified growth opportunities and reinforcing innovation pipelines across leading and mid-tier enterprises.
Brand and Channel StrategiesLeading companies focus on tailored brand development and multi-channel distribution to enhance market penetration. Strategic partnerships with research institutions and advanced technology providers strengthen customer relationships, while integrated collaboration networks improve service delivery and ensure sustained growth in a highly specialized environment.
Innovation Drivers and Technological Advancements
The industry is propelled by cutting-edge technological advancements in single-cell sequencing and proteomic analysis. Continuous innovation and collaborative R&D strategies drive novel product launches, while increased funding for precision medicine supports expansion of specialized tools and partnerships with key diagnostic and pharmaceutical entities.
Regional Momentum and Expansion
Rapid expansion in North America, Europe, and Asia-Pacific underscores a shift in regional strategies aimed at advancing genomics infrastructure. Cross-border collaboration, joint ventures, and public-private partnerships are increasing percentages of market share in emerging territories, further stimulating competitive differentiation and operational scalability.
Future Outlook
Looking ahead, the market is poised for sustained growth with heightened innovation in data integration and multi-omics approaches. Companies prioritizing adaptive strategies, flexible partnerships, and global R&D networks are expected to maintain leadership, while ongoing technological advancements foster new standards and redefine the future outlook of single-cell research solutions.
Key players in Single Cell Genomics and Proteomics Market include :
- Thermo Fisher Scientific
- 10x Genomics
- Illumina
- BD Biosciences
- QIAGEN
- Bio-Rad Laboratories
- Merck KGaA
- Agilent Technologies
- Bruker Corporation
- Promega Corporation
- Sartorius AG
- Standard BioTools
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Fluidigm Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Process Step
- Market Snapshot, By Technology
- Market Snapshot, By Components
- Market Snapshot, By Reagents
- Market Snapshot, By Proteomics Services & Software
- Market Snapshot, By Single Cell Genomics Applications
- Market Snapshot, By Application
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Single Cell Genomics and Proteomics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological advancements in single cell analysis techniques
- Increasing investments in genomics and proteomics research
- Restraints
- High cost associated with single cell genomics and proteomics technologies
- Complexity in data analysis and interpretation
- Opportunities
- Growing applications in personalized medicine
- Rising demand for biomarker discovery
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers
- Drivers, Restraints and Opportunities
- Market Segmentation
- Single Cell Genomics And Proteomics Market, By Process Step, 2021 - 2031 (USD Million)
- Cell Isolation
- Sample Preparation
- Genomics Analysis
- Single Cell Genomics And Proteomics Market, By Technology, 2021 - 2031 (USD Million)
- Tubing PCR
- qPCR
- Microarray
- Next-Generation Sequencing
- Others
- Single Cell Genomics And Proteomics Market, By Components, 2021 - 2031 (USD Million)
- Instruments
- Reagents
- Services
- Single Cell Genomics And Proteomics Market, By Reagents, 2021 - 2031 (USD Million)
- Immunoassay Reagents
- Spectroscopy Reagents
- Chromatography Reagents
- Protein Microarray Reagents
- X-Ray Crystallography Reagents
- Electrophoresis Reagents
- Protein Fractionation Reagents
- Single Cell Genomics And Proteomics Market, By Proteomics Services & Software, 2021 - 2031 (USD Million)
- Core Proteomics Services
- Bioinformatics Software & Services
- Single Cell Genomics And Proteomics Market, By Single Cell Genomics Applications, 2021 - 2031 (USD Million)
- Genomic Variation
- Subpopulation Characterization
- Circulating Tumor Cells
- Cell Differentiation & Reprograming Method
- Others
- Single Cell Genomics And Proteomics Market, By Application, 2021 - 2031 (USD Million)
- Drug Discovery
- Disease Diagnosis
- Others
- Single Cell Genomics And Proteomics Market, By End-Users, 2021 - 2031 (USD Million)
- Academic Institutes
- Biopharmaceutical Companies
- Clinical Research Institutes
- Single Cell Genomics and Proteomics Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Single Cell Genomics And Proteomics Market, By Process Step, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific
- 10x Genomics
- Illumina
- BD Biosciences
- QIAGEN
- Bio-Rad Laboratories
- Merck KGaA
- Agilent Technologies
- Bruker Corporation
- Promega Corporation
- Sartorius AG
- Standard BioTools
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Fluidigm Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market

